With a CAGR of 6.5% , Osteosynthesis Devices Market is expected to rise US$11 bn by 2023

The research report reveals that the global market for osteosynthesis devices is expected to reach US$11 bn by the end of 2023, after expanding at a CAGR of 6.5% from 2015 to 2023 in revenue. This revenue was slated to go over US$6.6 bn in 2016. Asia Pacific is expected to be an attractive region for the supply of osteosynthesis devices over the coming years, due to a swiftly evolving healthcare infrastructure and growing healthcare expenditure. North America, on the other hand, is likely to continue dominating both revenue and demand for osteosynthesis devices for the given forecast period. Non-degradable materials have so far been the more popular material type for the manufacture of osteosynthesis devices till 2023 and are likely to remain in the lead over the given forecast period by TMR. Internal fixation devices are expected to continue being the more popular type of osteosynthesis devices over the coming years.

View Full Report: http://www.transparencymarketresearch.com/osteosynthesis-devices-market.html

Rising Patient Count Runs Higher, Pushes Production Rate

“The number of people suffering from osteoarthritis and osteoporosis is usually found to be more common with the elderly. This number is currently very high and is creating a large enough demand for healthcare treatment options. For the coming years, this number is expected to increase even further and at a very swift alarming pace, thereby increasing the pressure of manufacture on the global osteosynthesis market,” states a TMR analyst.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5981

According to information and statistics provided by the globally leading organizations in healthcare, osteoporosis is currently attributed to induce more than 8.6 mn fractures every year across the world. More concerning is the regular rate of increment in this statistic, owing to the alarming rate of increase in the obese demographic, especially in developed economies, coupled with the growing number of road accidents and sports injuries across the world.

Market Growth Stifled by High Rate of Product Recalls

The average rate of failure in metal hip implants is 40%, which is extremely high and needs to be addressed by osteosynthesis device manufacturers as soon as possible. In 2010, DePuy Synthes had to recall nearly 93,000 osteosynthesis devices and implants after being sued for poor product quality. Eventually a settlement of US$4 mn was reached for all patients who were inconvenienced by the faulty implants. Situations such as these are creating a more negative image of the leading osteosynthesis device manufacturers across the world and have created a significant loss of credibility among consumers.

Request to download and view full ToC: http://www.transparencymarketresearch.com/report-toc/5981

Zimmer Biomet, Stryker Corporation, and DePuy Synthes have been the three leaders in the global osteosynthesis devices market for 2014, with a giant collective share in the market stood at 83.7%, according to a research report recently published by Transparency Market Research. The leaders in this highly consolidated market have proven themselves through a extensive product portfolios added to a string of successful mergers and acquisitions. For example, merger between Johnson & Johnson or DePuy with Synthes enabled the formation of a leading provider for osteosynthesis devices in the world.

Global Osteosynthesis Devices Market Report is available @ US$ 5795

The threat for new entrants is likely to remain moderate to low over the coming years, according to the TMR report. The presence of very strong players, high entry costs, and increasingly stringent regulations and guidelines are disbarring several hopefuls to the market. Patient compliance is becoming a core decisive element in the preference of osteosynthesis devices by patients and healthcare organizations, along with devices with superior safety certificates.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Leave a Reply

Designed by CyFocus.com
Powered by CyFocus.net